Astec LifeSciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
ASTEC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Astec LifeSciences Limited has submitted a compliance certificate for Q4 FY2025-26 (ending March 31, 2026) as required under SEBI regulations. The filing from their Registrar and Share Transfer Agent, Bigshare Services Private Limited, confirms that no securities were received for dematerialization during the quarter. Since there were no dematerialization requests, no share certificates were mutilated, cancelled, or had depositories' names substituted in the register of members. This is a routine regulatory compliance filing mandated for all listed companies.
No impact on shareholders or stock price. This is a standard procedural filing confirming zero dematerialization activity during the quarter. It does not indicate any corporate action or material change in the company's status.